Dr. Zhang on the Impact of the LATITUDE Study in Prostate Cancer

October 3, 2017
Tian Zhang, MD

Tian Zhang, MD, a medical instructor in the Department of Medicine, Duke University School of Medicine, discusses the impact of the LATITUDE study in prostate cancer.

Tian Zhang, MD, a medical instructor in the Department of Medicine, Duke University School of Medicine, discusses the impact of the LATITUDE study in prostate cancer.

Median progression-free survival and overall survival were both markedly improved with the addition of abiraterone acetate (Zytiga) to standard androgen-deprivation therapy (ADT) compared with ADT alone in patients with newly diagnosed, high-risk, metastatic prostate cancer.


x